Browsing Tag
Molecular diagnostics
11 posts
Co-Diagnostics (NASDAQ: CODX) secures Australian patent for Co-Dx PCR platform technologies
Co-Diagnostics lands its first patent for the Co-Dx PCR platform in Australia. Find out what it means for global expansion and diagnostic disruption.
Co-Diagnostics (Nasdaq: CODX) launches clinical trial for multiplex respiratory test as FDA approval push begins
Co-Diagnostics launches trial for flu, COVID-19, RSV test kit targeting FDA clearance. Learn how it plans to lead in decentralized respiratory diagnostics.
Inside Co-Diagnostics’ Saudi Arabia expansion: the CoMira JV bringing PCR manufacturing to the MENA region
Find out how Co-Diagnostics’ joint venture with Arabian Eagle is localizing its Co-Dx PCR platform through CoMira Diagnostics to transform Middle East testing access.
Is Imagion Biosystems (ASX: IBX) on the cusp of a breakout? FDA optimism lifts Phase 2 hopes, but market sentiment remains cautious
Imagion Biosystems is progressing toward a key FDA filing and Phase 2 trial for its HER2 imaging agent. Find out why IBX could be at a turning point.
Can Thermo Fisher’s new molecular test transform lung transplant care with faster rejection detection?
Discover how Thermo Fisher’s new AI-based MMDx Lung test improves early detection of lung transplant rejection and reshapes transplant diagnostics.
Is H5N1 the next big threat? Discover how Alveo’s new diagnostic could be a game changer
Alveo Technologies, Inc. (Alveo), a leader in molecular sensing and diagnostics, has announced a significant advancement in its…
Invivoscribe, Complete Genomics to develop biomarker tests for oncology research
Invivoscribe and Complete Genomics have announced a partnership aimed at developing and commercializing biomarker tests on the latter’s…
Lupin expands diagnostics network with Bengaluru regional reference lab
Lupin Diagnostics, a subsidiary of Indian pharma company Lupin, has opened its new regional reference laboratory in Bengaluru…
TCS roped in by QIAGEN to drive cloud transformation journey
Tata Consultancy Services (TCS) has been roped in by QIAGEN, a Germany-based provider of sample to insights solutions…
Oncocyte acquires Chronix Biomedical to enter immune therapy monitoring market
Oncocyte Corporation has closed its previously announced acquisition of Chronix Biomedical, a US-based molecular diagnostics company that develops…